Clinical Trials

1 studies in Neuromyelitis optica

1. Maintenance Plasma Exchange for Neuromyelitis Optica Scottsdale and Phoenix, AZ Rochester, MN View Summary
   Close

   Maintenance Plasma Exchange for Neuromyelitis Optica

   Location:

   Scottsdale and Phoenix, AZ Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system that is associated with autoantibodies to aquaporin-4. Treatment options for prevention of clinical relapses of NMO include immunosuppressive medications. Plasma exchange (PLEX) is commonly used as a rescue therapy for NMO relapses but ongoing, regular PLEX procedures (maintenance PLEX) is sometimes used to prevent relapses. This observational registry will record feasibility, tolerability, safety, and preliminary efficacy data regarding maintenance PLEX for participants with NMO, NMO spectrum disorders, and recurrent idiopathic longitudinally extensive transverse myelitis.

   NCT ID:

   NCT01500681

   IRB Number:

   10-007339

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Rochester: Mark Keegan, MD
                       
   Scottsdale: Dean Wingerchuk, MD 480-301-6710